General Surgery, All India Institute of Medical Sciences, Patna, Bihar, India.
Trauma Surgery & Critical Care, All India Institute of Medical Sciences, Patna, Bihar, India
Open Heart. 2023 Mar;10(1). doi: 10.1136/openhrt-2023-002256.
Worldwide, an estimated 10 million adults annually experience significant myocardial injury after non-cardiac surgery. Our aim is to assess whether preoperative and postoperative serum B-type natriuretic peptides levels (BNP) could be used as a predictor of postoperative complications in hypertensive and diabetic patients post non-cardiac surgery.
Prospective observational study.
Single tertiary-care centre in northern India.
This study included 260 adult participants with known hypertension and diabetes who were planned for elective non-cardiac surgery.
A preoperative BNP level (baseline BNP) was measured within 24 hours of surgery and another postoperative BNP level was measured within 24 hours of surgery.
The primary outcome was the change in BNP levels (delta BNP) between the postoperative and the preoperative BNP levels (baseline BNP) with respect to the baseline BNP and the development of postoperative complications within 30 days of surgery.
The study established a correlation between delta BNP and baseline BNP (Pearson's correlation coefficient=0.60; p=0.01). Our study found an increased serum BNP both in the preoperative period and the postoperative period in the patient group that developed complications, respectively (152.02 pg/mL±106.56 vs 44.90 pg/mL±44.22; t=4.120; p≤0.001); (313.99 pg/mL±121.29 vs 83.95 pg/mL±70.19; t=7.73; p≤0.001).
We found that an increased serum baseline and postoperative BNP is potentially important predictor for the development of postoperative complications. Serum BNP has the potential to emerge as a cost-effective test for risk-stratification for postoperative complications in patients undergoing non-cardiac surgery. It has promising prognostic advantages including modification of surgical procedures, deferral of surgery and the ability to tailor therapy postoperatively.
据估计,全球每年有 1000 万成年人在非心脏手术后经历严重的心肌损伤。我们的目的是评估术前和术后血清 B 型利钠肽水平(BNP)是否可作为高血压和糖尿病患者非心脏手术后术后并发症的预测指标。
前瞻性观察研究。
印度北部的一家单一的三级保健中心。
这项研究包括 260 名已知患有高血压和糖尿病的成年参与者,他们计划接受择期非心脏手术。
在手术前 24 小时内测量术前 BNP 水平(基线 BNP),并在手术后 24 小时内测量另一个术后 BNP 水平。
主要结果是术后 BNP 水平(术后 BNP)与术前 BNP 水平(基线 BNP)之间的变化,以及术后 30 天内发生术后并发症的情况。
该研究确立了 delta BNP 与基线 BNP 之间的相关性(Pearson 相关系数=0.60;p=0.01)。我们的研究发现,在发生并发症的患者组中,无论是在术前还是术后,血清 BNP 均升高(152.02pg/mL±106.56 vs 44.90pg/mL±44.22;t=4.120;p≤0.001);(313.99pg/mL±121.29 vs 83.95pg/mL±70.19;t=7.73;p≤0.001)。
我们发现,血清基线和术后 BNP 的升高可能是术后并发症发生的重要预测指标。血清 BNP 有可能成为一种具有成本效益的测试,用于对接受非心脏手术的患者进行术后并发症的风险分层。它具有有前途的预后优势,包括修改手术程序、推迟手术以及术后调整治疗的能力。